Academic Journals Database
Disseminating quality controlled scientific knowledge

Journal of the International AIDS Society

ISSN: 1758--2652
Publisher: International AIDS Society


ADD TO MY LIST
 
Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort PDF available

Author(s): Baumgarten A | Lutz T | Kreckel P | Wellmann E | Alshuth U | Mauss S | Rockstroh J
Volume: 13
Issue: Suppl 4
Year: 2010
Host genetics of HCV disease — IL28B PDF available

Author(s): Fellay J
Volume: 13
Issue: Suppl 4
Year: 2010
International perspectives on adherence and resistance to HIV antiretroviral therapy PDF available

Author(s): Bangsberg D
Volume: 13
Issue: Suppl 4
Year: 2010
Hepatitis C new drugs PDF available

Author(s): Wedemeyer H
Volume: 13
Issue: Suppl 4
Year: 2010
Mitochondrial ageing and antiretroviral therapy exposure PDF available

Author(s): Payne BAI | Hateley CA | Samuels DC | Wilson IJ | Santibanez-Koref M | Price DA | Chinnery PF
Volume: 13
Issue: Suppl 4
Year: 2010
Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC PDF available

Author(s): May MT | Gompels M | Sabin CA
Volume: 13
Issue: Suppl 4
Year: 2010
HIV therapy in an ageing population — the challenge of polypharmacy PDF available

Author(s): Back DJ
Volume: 13
Issue: Suppl 4
Year: 2010
Growing old with HIV — dealing with co-morbidities PDF available

Author(s): Powderly W
Volume: 13
Issue: Suppl 4
Year: 2010
Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children PDF available

Author(s): Zhang C | Denti P | Simonsson USH | Maartens G | Karlsson MO | McIlleron H
Volume: 13
Issue: Suppl 4
Year: 2010
The clinical development of NRTIs — cautionary tales PDF available

Author(s): Cooper D
Volume: 13
Issue: Suppl 4
Year: 2010
Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens PDF available

Author(s): Bommenel T | Meynard JL | Launay O | Simon A | Mahamat A | Martinez V | Gilquin J | Katlama C | Lascaux AS | Pradier C | Rouveix E | Costagliola D | Abgrall S
Volume: 13
Issue: Suppl 4
Year: 2010
Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa PDF available

Author(s): Pillay D | Goodall R | Gilks CF | Yirrell D | Gibb D | Spyer M | Kaleebu P | Munderi P | Kityo C | McCormick A | Nkalubo J | Lyagoba F | Chirara M | Hakim J
Volume: 13
Issue: Suppl 4
Year: 2010
The changing face of HIV resistance; HIV drug resistance north and south — what's next? PDF available

Author(s): Schapiro J
Volume: 13
Issue: Suppl 4
Year: 2010
Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial PDF available

Author(s): Clumeck N | Arribas JR | Pulick P | Fätkenheuer G | Hill A | Van Delft Y | Moecklinghoff C
Volume: 13
Issue: Suppl 4
Year: 2010
Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis PDF available

Author(s): Bierman WFW | Humphreys EH | van Agtmael MA | Boucher CA | Rutherford GW
Volume: 13
Issue: Suppl 4
Year: 2010
The state of PI monotherapy and NRTI-sparing therapy PDF available

Author(s): Arribas JR
Volume: 13
Issue: Suppl 4
Year: 2010
A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study PDF available

Author(s): Sönnerborg A | Mocroft A | Lundgren JD | Raben D | Gatell J | Vassilenko A | Hadziosmanovic V | Bergovac J | Sørensen H | Cusini M | Clumeck N | Gazzard B | Rockstroh J | Zuin M | D'Arminio Monforte A
Volume: 13
Issue: Suppl 4
Year: 2010
HIV treatment as prevention — human rights issues PDF available

Author(s): Amon J
Volume: 13
Issue: Suppl 4
Year: 2010
Test and treat — community perspectives PDF available

Author(s): Spire B
Volume: 13
Issue: Suppl 4
Year: 2010
Treatment-as-prevention: stopping the epidemic of HIV PDF available

Author(s): Williams B
Volume: 13
Issue: Suppl 4
Year: 2010
Treatment as prevention within the framework of current guidelines PDF available

Author(s): Montaner J
Volume: 13
Issue: Suppl 4
Year: 2010
Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients PDF available

Author(s): Valdez H | Chapman D | Biswai P | Lewis M | Craig C | Heera J | Ellery S | Swenson LC | Harrigan PR
Volume: 13
Issue: Suppl 4
Year: 2010
Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients PDF available

Author(s): Seclén E | Gonzalez M | Martín-Carbonero L | Gellermann H | Cairns V | Distel M | Kadus W | Soriano V | Poveda E
Volume: 13
Issue: Suppl 4
Year: 2010
ART achievements and challenges in Africa PDF available

Author(s): Hakim J
Volume: 13
Issue: Suppl 4
Year: 2010
The public health implications of antiretroviral therapy – 2011 and beyond PDF available

Author(s): De Cock KM
Volume: 13
Issue: Suppl 4
Year: 2010
Why suppression of HIV replication does not always make everything better PDF available

Author(s): Lederman M
Volume: 13
Issue: Suppl 4
Year: 2010
Antiretroviral regimen complexity as a predictor of adherence PDF available

Author(s): Boyle C | Wilson A | Treacy G | Sheehan G | Lambert J | Meegan C | Mallon P
Volume: 13
Issue: Suppl 4
Year: 2010
Does feedback of medication execution using MEMS caps aid adherence to HAART?: the MEMRI study (MEMS as Realistic Intervention) PDF available

Author(s): Davies S | Asghar S | Cooper V | Lange A | Robertson C | Vrijens B | White DJ
Volume: 13
Issue: Suppl 4
Year: 2010
Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals PDF available

Author(s): Pereira A | Lopes da Cruz JP | Carvalho C | Gonçalves C | Antunes F
Volume: 13
Issue: Suppl 4
Year: 2010
Relating protease inhibitor resistance at time of virological failure with drug exposure PDF available

Author(s): Van Luin M | Bannister WP | Paredes R | Phillips AN | Bruun J | Van Lunzen J | Kirk O | d'Arminio Monforte A | Cozzi-Lepri A | Burger DM
Volume: 13
Issue: Suppl 4
Year: 2010
Changing HIV guidelines: how to communicate treatment start PDF available

Author(s): Fehr J | Nicca D | Langewitz W | Haerry D | Battegay M
Volume: 13
Issue: Suppl 4
Year: 2010
Adherence, quality of life and number of daily pills in a large cross-sectional study PDF available

Author(s): Gianotti N | Galli L | Bocchiola B | Cahua T | Panzini P | Zandonà D | Salpietro S | Maillard M | Danise A | Pazzi A | Lazzarin A | Castagna A
Volume: 13
Issue: Suppl 4
Year: 2010
Administration of darunavir tablets in patients with difficulties in swallowing – two case reports PDF available

Author(s): Scholten S | Mauruschat S | Hindermann S | Ranneberg B
Volume: 13
Issue: Suppl 4
Year: 2010
Assessing the risk of birth defects associated with atazanavir exposure in pregnancy PDF available

Author(s): Esker S | Albano J | Tilson H | Uy J | Arikan D | Krantz K | Jiménez-Expósito MJ | Seekins D
Volume: 13
Issue: Suppl 4
Year: 2010
Efavirenz use and contraceptive methods in HIV-positive women in a large urban cohort PDF available

Author(s): Seaton RA | Fox R | MacConnachie A | Anderson P | Nandwani R | Peters E | Winter A | Taylor R
Volume: 13
Issue: Suppl 4
Year: 2010
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter study PDF available

Author(s): Madeddu G | Soddu V | Ricci E | Quirino T | Menzaghi B | Bellacosa C | Grosso C | Melzi S | Valsecchi L | Franzetti M | Vichi F | Penco G | Di Biagbio A | Pellicanò G | Corsico L | De Socio GVL | Mazzotta E | Parruti G | Guastavigna M | Orofino G | Mura MS | Bonfanti P
Volume: 13
Issue: Suppl 4
Year: 2010
Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety PDF available

Author(s): Perry MEO | Almaani N | Desai N | Fox J | Larbalestier N | Chilton D
Volume: 13
Issue: Suppl 4
Year: 2010
Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily PDF available

Author(s): Celesia BM | Coco C | Bisicchia F | Pellicanò G | Mughini MT | Palermo F | Nunnari G | Russo R
Volume: 13
Issue: Suppl 4
Year: 2010
Drug interactions in the elderly HIV-infected patient PDF available

Author(s): Coroiu C | Tollinchi F | Hittinger G | Mokhtari S | Granet P | Faucher-Zaegel O | Madrid A | Menard A | Mattei JL | Chadapaud S
Volume: 13
Issue: Suppl 4
Year: 2010
Continuing burden of HIV late presenters in the North East of England 2009 PDF available

Author(s): Premchand N | Golds K | Tan PY | Bittiner I | Sanker N | Ong ELC
Volume: 13
Issue: Suppl 4
Year: 2010
Behaviour and attitudes in HIV (BEAHIV): a national survey study to examine the level of agreement between physicians and patients in symptom reporting PDF available

Author(s): Rachlis A | Gill J | Harris M | Macleod J | Worthington C | Brunetta J | Tsang A | Hew H | Leith J | Camacho F | Turner D | Fraser C
Volume: 13
Issue: Suppl 4
Year: 2010
Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil PDF available

Author(s): Furtado JJD | Madruga JV | Bicudo EL | Eira M | Lopes MIB | Netto EM | de Oliveira MS | Leite OHM | Machado AA | Tupinambas U | de Andrade Neto JL | Lima MPJ | Wajsbrot DB | Cassoli LM
Volume: 13
Issue: Suppl 4
Year: 2010
Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort PDF available

Author(s): Cervero M | García Lacalle C | Agud JL | Perea R Torres | García-Benaya E | Jusdado J | Pons C Pérez | del Álamo M
Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence and factors associated with severe vitamin D deficiency in HIV/hepatitis C co-infected patients PDF available

Author(s): Surah S | Samarawickrama A | Campbell L | Kulasegaram R | Post F | Fisher M | Peters B | Fox J
Volume: 13
Issue: Suppl 4
Year: 2010
The serum level of 25-OH vitamin D and Th1 cytokine pattern in HIV infection versus hepatitis C virus infection and hepatitis B virus infection PDF available

Author(s): Iacob SA | Banica D | Panaitescu E | Cojocaru M | Iacob D
Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence of vitamin D deficiency: cross-sectional study of a hospital cohort of HIV-1 infected outpatients PDF available

Author(s): Cervero M | Alcázar V | García-La Calle C | Sanz R | Agud JL
Volume: 13
Issue: Suppl 4
Year: 2010
Rates of bone fractures in a cohort of HIV-infected adults in the UK PDF available

Author(s): Samarawickrama A | Malik R | Fisher M | Gilleece Y | Walker-Bone K
Volume: 13
Issue: Suppl 4
Year: 2010
Short-term variation of HIV tropism readouts in the absence of CCR5 antagonists PDF available

Author(s): Brumme CJ | Dong W | Chan D | Mo T | Swenson LC | Woods C | Demarest J | Heera J | Valdez H | Harrigan PR
Volume: 13
Issue: Suppl 4
Year: 2010
Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing PDF available

Author(s): Vandekerckhove LPR | Wensing AMJ | Kaiser R | Brun-Vezinet F | Clotet B | De Luca A | Dressler S | Garcia F | Geretti AM | Klimkait T | Korn K | Masquelier B | Perno CF | Schapiro J | Soriano V | Sönnerborg A | Vandamme ÀM | Verhofstede C | Walter H | Zazzi M | Boucher CA
Volume: 13
Issue: Suppl 4
Year: 2010
The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds PDF available

Author(s): Pironti A | Sönnerborg A | Zazzi M | Kaiser R | Struck D | Clotet B | Vandamme ÀM | Incardona F | Lengauer T | Rosen-Zvi M | Prosperi M
Volume: 13
Issue: Suppl 4
Year: 2010
Low-level residual viremia and risk of virological failure PDF available

Author(s): Cologni G | Soavi L | Leone S | Valenti D | Callegaro A | Gregis G | Suter F | Maggiolo F
Volume: 13
Issue: Suppl 4
Year: 2010
Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) PDF available

Author(s): Eron J | Livrozet JM | Morlat P | Lazzarin A | Katlama C | Hawkins T | Fujiwara T | Cuffe R | Vavro C | Santiago J | Ait-Khaled M | Min S | Yeo JM
Volume: 13
Issue: Suppl 4
Year: 2010
Once-daily S/GSK1349572 combination therapy in antiretroviral-naïve adults: rapid and potent 24-week antiviral responses in SPRING-1 (ING112276) PDF available

Author(s): Rockstroh J | Felizarta F | Maggiolo F | Pulido F | Stellbrink HJ | Tsybakova O | Yeni P | Almond S | Brothers C | Song I | Min S
Volume: 13
Issue: Suppl 4
Year: 2010
Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection PDF available

Author(s): Lodi S | Kücherer C | Kran AM | Masquelier B | Monforte A | Gill J | Dunn D | Pillay D | Porter K
Volume: 13
Issue: Suppl 4
Year: 2010
Lersivirine: a new NNRTI active across HIV-1 subtypes with a unique resistance profile PDF available

Author(s): Mori J | Westby M | Tawadrous M | van der Ryst E | Charles C
Volume: 13
Issue: Suppl 4
Year: 2010
Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients PDF available

Author(s): Cohen C | Molina JM | Cahn P | Clotet B | Fourie J | Grinsztejn B | Hao W | Johnson M | Supparatpinyo K | Crauwels HM | Rimsky L | Vanveggel S | Williams P | Boven K
Volume: 13
Issue: Suppl 4
Year: 2010
The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients PDF available

Author(s): Stellbrink HJ | Rugina S | Zagler C | Esser S | Castagna A | Gazzard B | Hill A | van Delft Y | Marks S
Volume: 13
Issue: Suppl 4
Year: 2010
HIV entry blocked by maraviroc can cause an overestimation of viral load PDF available

Author(s): Sloan RD | Kuhl BD | Kramer VG | Donahue DA | Bar-Magen T | Tressler R | Wainberg MA
Volume: 13
Issue: Suppl 4
Year: 2010
Maraviroc (MVC) increases CD4+ and CD8+ cells: long-term data from the MVC clinical development program PDF available

Author(s): Lazzarin A | Sierra-Madero JG | Battegay M | Mukwaya G | Burnside R | Chapman D | McCracken J | Portsmouth S | Valluri S | Valdez H | Heera J
Volume: 13
Issue: Suppl 4
Year: 2010
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART PDF available

Author(s): Rusconi S | Vitiello P | Adorni F | Colella E | Focà E | Capetti AF | Meraviglia P | Abeli C | Bonora S | D'Annunzio M | Di Biagio A | Di Pietro A | Butini L | Orofino G | Farina S | d'Ettorre G | Francisci D | Soria A | Buonomini AR | Tommasi C | Trotta MP | Capasso M | Merlini E | Marchetti GC
Volume: 13
Issue: Suppl 4
Year: 2010
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study PDF available

Author(s): Viard JP | Souberbielle JC | Kirk O | Knysz B | Losso M | Gatell J | Pedersen C | Bogner JR | Mocroft A | Lundgren JD
Volume: 13
Issue: Suppl 4
Year: 2010
Vitamin D and HIV: shine a light PDF available

Author(s): Currier J
Volume: 13
Issue: Suppl 4
Year: 2010
What affects the bone in our HIV-positive patients? PDF available

Author(s): Fux CA
Volume: 13
Issue: Suppl 4
Year: 2010
Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV-infected Thais PDF available

Author(s): Edwards-Jackson N | Kerr SJ | Tieu HV | Ananworanich J | Hammer SM | Ruxrungtham K | Phanuphak P | Avihingsanon A
Volume: 13
Issue: Suppl 4
Year: 2010
Fatal and non-fatal AIDS and non-AIDS events in HIV-1 infected patients with high CD4 counts PDF available

Author(s): Reekie J | Gatell J | Yust I | Bakowska E | Rachmanova A | Losso M | Krasnov M | Francioli P | Kowalska J | Mocroft A
Volume: 13
Issue: Suppl 4
Year: 2010
Early mortality following ART initiation in HIV-infected adults and children in Uganda and Zimbabwe PDF available

Author(s): Walker AS | Mugyenyi P | Munderi P | Hakim J | Kekitiinwa AA | Katabira E | Gilks CF | Kityo C | Nahirya-Ntege P | Nathoo K | Gibb D
Volume: 13
Issue: Suppl 4
Year: 2010
Adolescents with perinatally acquired HIV — coming your way PDF available

Author(s): Foster C
Volume: 13
Issue: Suppl 4
Year: 2010
HIV/HAART and the brain — what's going on? PDF available

Author(s): Portegies P
Volume: 13
Issue: Suppl 4
Year: 2010
How early to start: what do observational data suggest? PDF available

Author(s): Sterne J
Volume: 13
Issue: Suppl 4
Year: 2010
The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers PDF available

Author(s): Ashby J | Garvey LJ | Erlwein OW | Lamba H | Weston R | Legg K | McClure MO | Dickinson L | D'Avolio A | Back DJ | Winston A
Volume: 13
Issue: Suppl 4
Year: 2010
Older HIV-infected individuals present late and have a higher mortality: a UK clinic cohort study PDF available

Author(s): Iwuji CC | Pao D | Gilleece Y | Fisher M | Churchill D
Volume: 13
Issue: Suppl 4
Year: 2010
BEST: Better Equipped to Start Treatment PDF available

Author(s): Bennett J
Volume: 13
Issue: Suppl 4
Year: 2010
A method to estimate the number of people in a country or region with HIV who are undiagnosed and in need of ART PDF available

Author(s): Lodwick RK | Sabin CA | Phillips AN
Volume: 13
Issue: Suppl 4
Year: 2010
Pregnancy decisions and contraceptive use among HIV-positive women: a study in a large urban clinic in sub-Saharan Africa PDF available

Author(s): Walusimbi J | Birabwa E | Nabankema E | AnneMarie A | Lutalo I | Nakiwooga A
Volume: 13
Issue: Suppl 4
Year: 2010
Amniocentesis is a low-risk procedure in HIV-treated pregnant women PDF available

Author(s): Simoes MM | Marques CO | Albergaria F | Guerreiro C | Pereira A | Correia J | Castela J
Volume: 13
Issue: Suppl 4
Year: 2010
A complex of measures effectiveness in reducing mother-to-child HIV transmission PDF available

Author(s): Minaeva SV | Moshkovich GF
Volume: 13
Issue: Suppl 4
Year: 2010
Use of antiretroviral therapy during pregnancy among HIV-infected women attending an urban care centre PDF available

Author(s): Ssewankambo F | Nalugwa C | Sempa J | Walusimbi J | Kambugu A
Volume: 13
Issue: Suppl 4
Year: 2010
Antiretroviral strategies for the treatment of pregnant HIV+ women and prevention of perinatal HIV transmission in Dodoma, Tanzania: AMANI Study PDF available

Author(s): Liuzzi G | Vairo F | Chaula Z | Nguhuni B | Nicastri E | Bevilacqua N | Cannas A | Paglia MG | Ippolito G
Volume: 13
Issue: Suppl 4
Year: 2010
Factors associated with treatment modification during the first year of contemporary HAART PDF available

Author(s): Martin N | Perez-Valero I | San Jose Valiente B | Mora M | Bernardino-Serna JI | Gonzalez J | Gaya F | Zamora FX | Pena JM | Arribas JR
Volume: 13
Issue: Suppl 4
Year: 2010
Minority M184V variants in women exposed to 3TC/FTC-containing lopinavir-ritonavir (LPVr) regimens in pregnancy PDF available

Author(s): Surah S | Oshea S | Costelloe S | Hanlon M | Mullen J | Chrystie I | Taylor GP | De Ruiter A
Volume: 13
Issue: Suppl 4
Year: 2010
High preterm delivery rates associated with initiation of HAART during pregnancy PDF available

Author(s): Taylor GP | Douglas M | Smith J
Volume: 13
Issue: Suppl 4
Year: 2010
Salvage therapy with raltegravir in a 3-month-old infant PDF available

Author(s): Brolund AB | Ilchmann C | Ganschow R | Degen O
Volume: 13
Issue: Suppl 4
Year: 2010
Audit of outcomes of early initiation of antiretroviral therapy in children admitted to the paediatric wards at Kilifi district hospital, Kenya PDF available

Author(s): Nabwera HM | Mwaringa S | Kimutai R | Berkley JA
Volume: 13
Issue: Suppl 4
Year: 2010
Promoting presumptive diagnosis of severe HIV disease to increase uptake of antiretroviral therapy in HIV-infected infants PDF available

Author(s): Chiwoko J | Mhango E | Phiri S | Weigel R
Volume: 13
Issue: Suppl 4
Year: 2010
Feasibility and effectiveness of combination antiretroviral therapy in HIV-infected infants in Pietermaritzburg, South Africa PDF available

Author(s): Van der Linden D | Purchase S | McKerrow NH
Volume: 13
Issue: Suppl 4
Year: 2010
Comparative evaluation of ARV therapy efficiency among patients at the Kiev regional AIDS center PDF available

Author(s): Yurchenko YO | Stepchenkova T | Karnets KI | Martinenko MO
Volume: 13
Issue: Suppl 4
Year: 2010
What drives a normal relation between T-CD4 and T-CD8? PDF available

Author(s): Badura R | Antunes RJG | Janeiro N | Afonso C | Antunes F
Volume: 13
Issue: Suppl 4
Year: 2010
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients PDF available

Author(s): Parczewski M | Leszczyszyn-Pynka M | Bander D | Urbañska A | Kaczmarczyk M | Ciechanowicz S | Boron-Kaczmarska A
Volume: 13
Issue: Suppl 4
Year: 2010
Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen PDF available

Author(s): Wikman P | Safont P | Perez-Elías MJ | Moreno A | Dronda F | Moreno S | Casado JL
Volume: 13
Issue: Suppl 4
Year: 2010
Insights into antiretroviral treatment changes in previously naïve patients: results of a Portuguese cohort PDF available

Author(s): Silva C | Bento D | Rijo J | Alfaiate D | Aldir I | Araújo C | Farinha H | Mansinho K
Volume: 13
Issue: Suppl 4
Year: 2010
Effect of lipemia and bilirubinemia on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: a five-year analysis PDF available

Author(s): Pattery T | Van Cauwenberge A | Van Hove M | Smits V | Van Soom K | Villacian J
Volume: 13
Issue: Suppl 4
Year: 2010
Feasibility of testing antibodies to HIV from filter paper using HIV rapid test kits PDF available

Author(s): Ganesan A | Thatchinamoorthy G | Saramini S
Volume: 13
Issue: Suppl 4
Year: 2010
High prevalence of the UGT1A1*28 variant in HIV-infected individuals in Greece PDF available

Author(s): Panagopoulos P | Paraskevis D | Sypsa V | Detsika M | Protopapas K | Sakka V | Poulakou G | Papadopoulos A | Petrikkos G | Hatzakis A
Volume: 13
Issue: Suppl 4
Year: 2010
Genotype testing in HIV-infected pregnant women PDF available

Author(s): Afonso C | Zagalo A | Janeiro N | Antunes F
Volume: 13
Issue: Suppl 4
Year: 2010
Haemoglobin and anaemia in the SMART study PDF available

Author(s): Mocroft A | Lifson AR | Touloumi G | Neuhaus J | Fox Z | Palfreeman A | Vjecha M | Hodder S | De Wit S | Lundgren JD | Phillips AN
Volume: 13
Issue: Suppl 4
Year: 2010
Pro-viral DNA and antiretroviral treatment simplification PDF available

Author(s): Zucman D | Rouzioux C | Avettand-Fenoel V
Volume: 13
Issue: Suppl 4
Year: 2010
Development of drug resistance among HIV-1 F1 sub-type patients with treatment failure PDF available

Author(s): Temereanca A | Sultana CM | Manolescu L | Vagu C | Grancea C | Ruta S
Volume: 13
Issue: Suppl 4
Year: 2010
Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009) PDF available

Author(s): Pérez L | Aleman J | Correa C | Pérez J | Fonseca C | Aragones C | Pérez D | Alvarez A | Vandamme AM | Kourí V | Van Laethem K
Volume: 13
Issue: Suppl 4
Year: 2010
HIV drug resistance in children with treatment failure to first-line regimens in Ho Chi Minh City, Vietnam PDF available

Author(s): Nhung VTT | Colby D | Khanh TH | Viet TT | Lu D | Thuy HT | An B | Giang LT
Volume: 13
Issue: Suppl 4
Year: 2010
Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients PDF available

Author(s): Caldas C | Andrade P | Azevedo C | Piñeiro C | Serrão R | Soares J | Marques R | Sarmento A
Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy PDF available

Author(s): Gaytán-Martínez JE | Mata-Marín JA | Gutierrez-Escolano F | Pérez-Saleme L | Treviño-Pérez S | Vázquez-Rosales JG | Matías-Juan N | Díaz-Ramos RD | Arias-Flores R
Volume: 13
Issue: Suppl 4
Year: 2010
Is extended resistance to the historical antiretroviral drugs & drug classes still a risk factor for HIV progression? PDF available

Author(s): Zaccarelli M | Lorenzini P | Marconi P | Forbici F | Gori C | Sette P | Ceccherini-Silberstein F | Narciso P | Perno CF | Antinori A
Volume: 13
Issue: Suppl 4
Year: 2010
Abstract withdrawn PDF available

Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens PDF available

Author(s): Marcelin AG | Charpentier C | Ferreira C | Wirden M | Lemarchand C | Descamps D | Calvez V
Volume: 13
Issue: Suppl 4
Year: 2010
High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil PDF available

Author(s): Pena N | Azevedo R | Castro D | Diaz R | Komninakis S
Volume: 13
Issue: Suppl 4
Year: 2010
Resistance after viral failure on atazanavir-containing therapy: multinational clinical cohort (BMS AI424-128 — 'IMPACT') final analysis PDF available

Author(s): Zolopa A | Towner W | Lazzarin A | Fätkenheuer G | Butcher D | Uy J
Volume: 13
Issue: Suppl 4
Year: 2010
Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy PDF available

Author(s): Marcelin AG | Charpentier C | Wirden M | Descamps D | Calvez V
Volume: 13
Issue: Suppl 4
Year: 2010
Changing prevalence of darunavir resistance-associated mutations (DRV RAMs) in clinical samples received for routine resistance testing: 2003-2009 PDF available

Author(s): De La Rosa G | Pattery T | Picchio G | Lathouwers E | Villacian J | Van der Borght K
Volume: 13
Issue: Suppl 4
Year: 2010
Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs PDF available

Author(s): Pulido F | Arribas JR | Hill A | van Delft Y | Moecklinghoff C
Volume: 13
Issue: Suppl 4
Year: 2010
Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRV PDF available

Author(s): Rockstroh J | Eron J | Cooper D | Steigbigel R | Nguyen BY | Xu X | Wan H | Rodgers A | Miller M | Leavitt R | Sklar P | Teppler H
Volume: 13
Issue: Suppl 4
Year: 2010
Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort PDF available

Author(s): van Lunzen J | Fätkenheuer G | Lutz T | Klauke S | Mauss S | Knechten H | Braun P | Gallo L | Goldbach J
Volume: 13
Issue: Suppl 4
Year: 2010
Clinical application of genotypic co-receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort PDF available

Author(s): Obermeier MJ | Carganico A | Dupke S | Schranz D | Cordes C | Freiwald M | Klausen G | Köppe S | Schuler C | Mayr C | Schleehauf D | Berg T | Krznaric I | Baumgarten A
Volume: 13
Issue: Suppl 4
Year: 2010
Population and ultra-deep sequencing for tropism determination are correlated with Trofile ES: genotypic re-analysis of the A4001078 maraviroc study PDF available

Author(s): Portsmouth S | Valluri S | Daeumer M | Thiele B | Valdez H | Lewis M | Craig C | Thielen A | James I | Demarest J | Heera J
Volume: 13
Issue: Suppl 4
Year: 2010
Detection of HIV type 1 mutations on the pol region in untreated patients in Northern Vietnam: determination of drug resistance and subtypes PDF available

Author(s): Ranger-Rogez S | Al Jawhari M | Nguyen B | Pham Hong N | Tran Quoc T | Pascual J | Doll J | Harzic M | Viretto G | Weinbreck P
Volume: 13
Issue: Suppl 4
Year: 2010
Analysis of transmitted drug resistance, resistance mutations and future antiretroviral efficacy in HIV-1 subtype F infected-patients prior to therapy PDF available

Author(s): Manolescu LSC | Sultana CM | Vagu C | Temereanca A | Ruta SM
Volume: 13
Issue: Suppl 4
Year: 2010
Transmitted drug resistance associated with transmission clusters in newly diagnosed antiretroviral-naïve patients in Northern Greece PDF available

Author(s): Skoura L | Metallidis S | Buckton AJ | Mbisa JL | Pilalas D | Papadimitriou E | Papoutsi A | Haidich AB | Valagouti D | Tsachouridou O | Antoniadou ZA | Kollaras P | Nikolaidis P | Malisiovas N
Volume: 13
Issue: Suppl 4
Year: 2010
Identifying causes of loss to follow up in newly diagnosed HIV-infected patients PDF available

Author(s): Fridman V | Bello NS | Lasala MB
Volume: 13
Issue: Suppl 4
Year: 2010
Naïve patients receiving TDF/FTC-EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pill PDF available

Author(s): Perez-Valero I | Martin N | Valiente B | Bernardino-Serna JI | Mora M | Gaya F | Gonzalez J | Zamora FX | Pena JM | Arribas JR
Volume: 13
Issue: Suppl 4
Year: 2010
Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials PDF available

Author(s): Nelson M | Amaya G | Clumeck N | Arns Da Cunha C | Jayaweera D | Junod P | Taisheng L | Tebas P | Stevens M | Buelens A | Vanveggel S | Boven K
Volume: 13
Issue: Suppl 4
Year: 2010
Sex matters: retrospective data collection on the date of commencement of ART for HIV-positive women and men in the German KompNet cohort (1991-2009) PDF available

Author(s): Krznaric I | Wienbreyer A | Zoufaly A | Kreckel P | Esser S | Harrer T | Jansen K | Michalik C | Hertling S
Volume: 13
Issue: Suppl 4
Year: 2010
Efficacy and safety of therapy of chronic hepatitis B with telbivudine (LdT) in patients with HIV-infection without HAART PDF available

Author(s): Tsarenko SP | Kravchenko AV | Kanestri VG | Maximov SL
Volume: 13
Issue: Suppl 4
Year: 2010
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy PDF available

Author(s): Labarga P | Vispo ME | Guardiola JM | Miralles C | Martín-Carbonero L | Portu J | Barreiro P | Miralles P | Morello J | Tellez MJ | Bancalero P | Asensi V | Rallón NI | Santos I | Morano L | Aguirrebengoa K | Rios MJ | Rubio R | Neukam K | González-Lahoz J | Soriano V
Volume: 13
Issue: Suppl 4
Year: 2010
Effectiveness of pegylated interferon alfa plus HAART in HIV/HBV treatment-naïve coinfected patients PDF available

Author(s): Mata-Marín JA | Arroyo-Anduiza CI | Arias-Flores R | Gaytán-Martínez JE
Volume: 13
Issue: Suppl 4
Year: 2010
No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV PDF available

Author(s): Fernández-Montero JV | Martín-Carbonero L | Barreiro P | Rallón NI | Benito JM | González-Lahoz J | Soriano V
Volume: 13
Issue: Suppl 4
Year: 2010
Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B? PDF available

Author(s): Martín-Carbonero L | Rallón NI | Benito JM | Poveda E | González-Lahoz J | Soriano V
Volume: 13
Issue: Suppl 4
Year: 2010
Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients PDF available

Author(s): Ferrara S | Tartaglia A | Santantonio T | Grisorio B
Volume: 13
Issue: Suppl 4
Year: 2010
Correlates of hepatic stiffness by FibroScan© in a multicentric Italian cohort of HIV-infected patients PDF available

Author(s): Tarquini P | Sozio F | Marchionni E | Gabrielli E | Polilli E | Ancarani F | Di Giammartino D | Manzoli LM | Parruti G
Volume: 13
Issue: Suppl 4
Year: 2010
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the 'real-life setting' proves the concept PDF available

Author(s): Ingiliz P | Obermeier MJ | Weitner L | Cordes C | Moll A | Hintsche B | Schlote F | Köppe S | Mayr C | Baumgarten A
Volume: 13
Issue: Suppl 4
Year: 2010
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México PDF available

Author(s): Mata-Marín JA | Gaytán-Martínez JE | Arroyo-Anduiza CI | Calderón-Rodriguez G
Volume: 13
Issue: Suppl 4
Year: 2010
Increasing numbers of acute hepatitis C infections in HIV-infected MSM and high reinfection rates following SVR PDF available

Author(s): Stellbrink HJ | Schewe CK | Vogel M | Noah C
Volume: 13
Issue: Suppl 4
Year: 2010
Health-related quality of life and fatigue in HIV-1 infected patients diagnosed during primary versus chronic infection PDF available

Author(s): Steingrover R | Nievaard MAF | Lange JMA | Nieuwkerk PT | Prins JM
Volume: 13
Issue: Suppl 4
Year: 2010
Epidemiological features, therapeutic strategies and long-term immunological outcomes in virologically suppressed HIV+ very late presenters PDF available

Author(s): Martinelli L | Francisci D | Sgrelli A | Baldelli F
Volume: 13
Issue: Suppl 4
Year: 2010
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users PDF available

Author(s): Conway B | Barrieshee A | Tossonian HK | Wight K | Jassemi S | Tong M | Knight E | Gallagher L | Duncan F | DeVlaming S
Volume: 13
Issue: Suppl 4
Year: 2010
Sudden unexplained death in a patient with HIV and MDR-TB PDF available

Author(s): Boxall E | Milne J | Peters E | Sykes C
Volume: 13
Issue: Suppl 4
Year: 2010
Enfuvirtide in therapy at patients with HIV-infection and tuberculosis PDF available

Author(s): Kravchenko AV | Kuznetsova AV | Kozyrev OA | Lukyanova VA | Kanestri VG
Volume: 13
Issue: Suppl 4
Year: 2010
Therapy of the patients with HIV/TB infection and dynamics of level 'naïve' CD4-lymphocytes PDF available

Author(s): Popova AA | Kravchenko AV | Kozhevnikova GM | Serebrovskaya LV
Volume: 13
Issue: Suppl 4
Year: 2010
Generalized tuberculosis in HIV-infected patients with AIDS PDF available

Author(s): Zimina VN | Vasilieva IA | Kravchenko AV | Batyrov FA
Volume: 13
Issue: Suppl 4
Year: 2010
A minority of tuberculosis cases occurring during HIV care is possibly preventable PDF available

Author(s): Skeie L | Skrede T | Maeland A
Volume: 13
Issue: Suppl 4
Year: 2010
Epidemiology of HIV-associated tuberculosis (TB) co-infection in Krasnoyarsk region, Russian Federation PDF available

Author(s): Chaychuk TA | Gankina NU | Nikonova OG
Volume: 13
Issue: Suppl 4
Year: 2010
Immunological diagnosis of CMV infection in HIV-infected patients PDF available

Author(s): Dumitru IM | Rugina S | Dumitru E | Cernat RC | Diaconu S | Mitroi C
Volume: 13
Issue: Suppl 4
Year: 2010
Opportunistic infections (OIs) present in HIV-seropositive patients: a study PDF available

Author(s): Ramaiah K | Sudha Rani B | Anand R | Ramola S | Satish Babu P | Ramesh Babu R
Volume: 13
Issue: Suppl 4
Year: 2010
Treatment of chronic invasive fungal sinusitis with voriconazole in an HIV patient PDF available

Author(s): Ho A | McGarry G | Peters E
Volume: 13
Issue: Suppl 4
Year: 2010
Immunological response among patients with undetectable viral load followed for 5 years PDF available

Author(s): Piñeiro C | Santos AS | Cardoso S | Nuak J | Lucas R | Ferreira A | Xerinda S | Tavares M | Marques R | Sarmento A
Volume: 13
Issue: Suppl 4
Year: 2010
The use of a darunavir/ritonavir once-daily regimen in two pregnant women PDF available

Author(s): Lambert JS | Else LJ | Jackson V | Dickinson L | Back DJ | Brennan M | Weldridge C | Coulter-Smith S | Gibbons S | Khoo SH
Volume: 13
Issue: Suppl 4
Year: 2010
Moringa oleifera supplementation by patients on antiretroviral therapy PDF available

Author(s): Monera TG | Maponga CC
Volume: 13
Issue: Suppl 4
Year: 2010
Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients PDF available

Author(s): Moltó J | Valle M | Miranda C | Cedeño S | Negredo E | Barbanoj MJ | Clotet B
Volume: 13
Issue: Suppl 4
Year: 2010
Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral-naïve, HIV-1-infected patients in ECHO and THRIVE PDF available

Author(s): Crauwels HM | van Schaick E | van Heeswijk RPG | Vanveggel S | Boven K | Vis P
Volume: 13
Issue: Suppl 4
Year: 2010
Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial PDF available

Author(s): Sekar V | De La Rosa G | Van de Casteele T | Spinosa-Guzman S | Vis P | Hoetelmans RMW
Volume: 13
Issue: Suppl 4
Year: 2010
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients PDF available

Author(s): Dickinson L | Jackson AGA | Garvey LJ | Watson V | Khoo SH | Winston A | Boffito M | Davies GR | Back DJ
Volume: 13
Issue: Suppl 4
Year: 2010
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients PDF available

Author(s): Zhang Y | Owen A | Egan D | Sarfo SF
Volume: 13
Issue: Suppl 4
Year: 2010
PK/PD modeling supports the dose-escalation decision in VIKING PDF available

Author(s): Lovern M | Underwood M | Nichols G | Song I
Volume: 13
Issue: Suppl 4
Year: 2010
Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi PDF available

Author(s): Dickinson L | Chaponda M | Carr D | van Oosterhout JJ | Kumwenda J | Lalloo DG | Pirmohamed M | Heyderman R | Khoo SH
Volume: 13
Issue: Suppl 4
Year: 2010
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers PDF available

Author(s): Jackson AGA | Hill A | Else LJ | Back DJ | Morley R | Puls R | Amin J | Lin E | Boffito M
Volume: 13
Issue: Suppl 4
Year: 2010
Efficient immune reconstitution in HIV+ naïve patients (pts) starting a first lopinavir/ritonavir-containing regimen with low CD4 counts PDF available

Author(s): Merlini E | Sinigaglia E | Carpani G | Bini T | d'Arminio Monforte A | Marchetti GC
Volume: 13
Issue: Suppl 4
Year: 2010
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load PDF available

Author(s): Calcagno A | Milia MG | D'Avolio A | Ndayishimiyae P | Dusabimana P | Bonora S | Cusato J | Simiele M | Rostagno R | Siccardi M | Audagnotto S | Ghisetti V | Di Perri G
Volume: 13
Issue: Suppl 4
Year: 2010
SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients PDF available

Author(s): Siccardi M | D'Avolio A | Baietto L | Simiele M | Bonora S | Back DJ | Di Perri G | Owen A
Volume: 13
Issue: Suppl 4
Year: 2010
Therapeutic drug monitoring (TDM) of atazanavir in pregnancy PDF available

Author(s): Else LJ | Jackson V | Brennan M | Breiden J | Weldridge C | Coulter-Smith S | Back DJ | Khoo SH | Lambert J
Volume: 13
Issue: Suppl 4
Year: 2010
Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children PDF available

Author(s): Gitta PK | Kendall L | Musiime V | Adkison K | Kekitiinwa AA | Ferrier A | Opilo O | Lou Y | Bwakura-Dangarembi MF | Nahirya-Ntege P | Bakeera-Kitaka S | Ssenyonga M | Snowden W | Burger D | Walker AS | Gibb D
Volume: 13
Issue: Suppl 4
Year: 2010
T-CD4+ cell count at the date of the HIV diagnosis PDF available

Author(s): Domingues da Silva AR | Mendez J | e Castro R
Volume: 13
Issue: Suppl 4
Year: 2010
The impact of late presentation: analysis of a cohort of 313 Portuguese patients PDF available

Author(s): Alfaiate D | Miranda AC | Rijo J | Fernandes D | Borges F | Farinha H | Mansinho K
Volume: 13
Issue: Suppl 4
Year: 2010
Five-year outcomes of HAART at a non-governmental treatment center in Lima, Peru PDF available

Author(s): Castillo N | Agurto C | Benites C | Hidalgo JA
Volume: 13
Issue: Suppl 4
Year: 2010
Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia PDF available

Author(s): Bloch M | Hoy J | Cunningham N | Roth N | Andrianopoulos N | Rayner C | Carr A
Volume: 13
Issue: Suppl 4
Year: 2010
Audit of telephone HIV clinics: effective and acceptable PDF available

Author(s): Woolley WFC | Babu C | Sukthankar A | McQuillan O
Volume: 13
Issue: Suppl 4
Year: 2010
Impact of timing HAART initiation on immune status and clinical course in the cohort of the German competence network for HIV/AIDS PDF available

Author(s): Plettenberg A | Brockmeyer NH | Haastert B | Dupke S | Schewe CK | Rausch M | Hower M | Arendt G | Jansen K | KompNet HIV
Volume: 13
Issue: Suppl 4
Year: 2010
A high occurrence of late presenters and missed HIV diagnosis in clinical care in Sweden PDF available

Author(s): Brännström J | Svedhem V | Yilmaz A | Blaxhult A | Wendahl S | Sönnerborg A
Volume: 13
Issue: Suppl 4
Year: 2010
Offering HIV testing in an emergency admission unit in Newcastle upon Tyne, UK — a pilot audit study PDF available

Author(s): Ellis S | Graham L | Price DA | Ong ELC
Volume: 13
Issue: Suppl 4
Year: 2010
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study PDF available

Author(s): Ghosn J | Chermak A | Houssaini A | Peytavin G | Lambert-Niclot S | Eychenne N | Slama L | Brunet A | Duvivier C | Simon A | Marcelin AG | Flandre P | Katlama C
Volume: 13
Issue: Suppl 4
Year: 2010
Short-course intensification with enfuvirtide in virologic failure: impact on intracellular HIV reservoir and on viral tropism (INNOVE study) PDF available

Author(s): Ghosn J | Delaugerre C | Pinta A | Pierre N | Etienne D | Raffi F | Morand-Joubert L
Volume: 13
Issue: Suppl 4
Year: 2010
ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults PDF available

Author(s): Orkin C | DeJesus E | Khanlou H | Stoehr A | Supparatpinyo K | Van de Casteele T | Lathouwers E | Spinosa-Guzman S
Volume: 13
Issue: Suppl 4
Year: 2010
Immunologic impact of maraviroc in clinical practice of a university hospital PDF available

Author(s): Paniagua S | Lopez N | Romera I | Larisgoitia A | Cano J | Saez M
Volume: 13
Issue: Suppl 4
Year: 2010
Long-term follow-up of HIV-infected patients in salvage therapy with raltegravir plus optimized background regimens: a multicentre Italian experience PDF available

Author(s): Landonio S | Meraviglia P | Capetti AF | Di Biagio A | Lo Caputo S | Sterrantino G | Ammassari A | Menzaghi B | Franzetti M | De Socio G | Pellicanò G | Mazzotta E | Zucchi P | Rizzardini G
Volume: 13
Issue: Suppl 4
Year: 2010
Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008 PDF available

Author(s): Bruyand M | Geffard S | Lawson-Ayayi S | Dauchy F | Miremont-Salamé G | Greib C | Farbos S | Morlat P | Dabis F
Volume: 13
Issue: Suppl 4
Year: 2010
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users PDF available

Author(s): Tossonian HK | Raffa JD | Alenezi O | Anderson K | Jassemi S | Wight K | DeVlaming S | Conway B
Volume: 13
Issue: Suppl 4
Year: 2010
Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice PDF available

Author(s): Llibre JM | Martínez E | Barreiro P | Escrig R | Ribera E | Cervantes M | Imaz A | Gutierrez F | Knobel H | Ornelas A | Zamora FX | Clotet B
Volume: 13
Issue: Suppl 4
Year: 2010
Portuguese cohort: raltegravir with optimized background therapy (OBT) in multiple-experienced HIV1- and HIV2-infected patients PDF available

Author(s): Doroana M | Piñeiro C | Maltez F | Fonseca P | Oliveira J | Mansinho K | Horta A | Teófilo E | Aguas M | Germano I | Faria D
Volume: 13
Issue: Suppl 4
Year: 2010
Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach PDF available

Author(s): Grant A | Kamuntu Y | Read P | Kulasegaram R
Volume: 13
Issue: Suppl 4
Year: 2010
Integrase inhibitor-based treatment in clinical practice PDF available

Author(s): Cenderello G | Piscopo R | Feasi M | Penco G | Bobbio N | Cassola G
Volume: 13
Issue: Suppl 4
Year: 2010
Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients PDF available

Author(s): Jansen K | Sönnerborg A | Pugliese P | Biguenet S | Eychenne JL | Brockmeyer NH | Michalik C | Dupke S | Jaeger H | Plettenberg A | Butcher D | Jiménez-Expósito MJ | KompNet HIV
Volume: 13
Issue: Suppl 4
Year: 2010
Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1 PDF available

Author(s): Maroldo L | Fredrick LM | Robinson-Morgan K | Trinh R | Podsadecki TJ
Volume: 13
Issue: Suppl 4
Year: 2010
The management of acute retroviral syndrome PDF available

Author(s): Hristea A | Petre R | Gliga S | Olaru I | Ion M | Moroti R | Popescu C | Mihailescu R | Radulescu M | Arama V
Volume: 13
Issue: Suppl 4
Year: 2010
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study PDF available

Author(s): Schneider L | Houssaini A | Lambert S | Peytavin G | Agher R | Chermak A | Flandre P | Calvez V | Marcelin AG | Ghosn J | Katlama C
Volume: 13
Issue: Suppl 4
Year: 2010
Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort PDF available

Author(s): van Lunzen J | Gorriahn D | Wünsche T | Dupke S | Gute P | Schewe CK | Ranneberg B
Volume: 13
Issue: Suppl 4
Year: 2010
Darunavir in experienced patients PDF available

Author(s): Sterrantino G | Borchi B | Trotta M | Bartolozzi D | Leoncini F
Volume: 13
Issue: Suppl 4
Year: 2010
Health-related quality of life (HRQoL) assessment with once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial PDF available

Author(s): Spinosa-Guzman S | Van de Casteele T | De La Rosa G | De Doncker P
Volume: 13
Issue: Suppl 4
Year: 2010
Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN PDF available

Author(s): Sension M | Arns Da Cunha C | Domingo P | Supparatpinyo K | Van De Casteele T | De Doncker P | Tomaka F
Volume: 13
Issue: Suppl 4
Year: 2010
Changing antiretrovirals whilst viral load PDF available

Author(s): Mocroft A
Volume: 13
Issue: Suppl 4
Year: 2010
Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen PDF available

Author(s): Aragão F | Vaz Pinto I | Vera J
Volume: 13
Issue: Suppl 4
Year: 2010
Late versus non-late presentation of HIV/AIDS: an economic impact analysis PDF available

Author(s): Grabmeier-Pfistershammer K | Rieger A | Schroeck T | Schlag M
Volume: 13
Issue: Suppl 4
Year: 2010
Cost-efficacy analysis of the MONET trial using Spanish antiretroviral drug prices PDF available

Author(s): Arribas JR | Hill A | Garcia I | Anceau A
Volume: 13
Issue: Suppl 4
Year: 2010
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy PDF available

Author(s): Broder MS | Juday T | Uy J | Chang EY | Bentley TGK
Volume: 13
Issue: Suppl 4
Year: 2010
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects PDF available

Author(s): Spagnuolo V | Galli L | Salpietro S | Vinci C | Cossarini F | Travi G | Rubinacci A | Mignogna G | Cernuschi M | Bossolasco S | Lazzarin A | Castagna A
Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era PDF available

Author(s): Madeddu G | Fois AG | Calia GM | Becciu F | Piras B | Fiori ML | Spada V | Lovigu C | Mannazzu M | Pirina P | Mura MS
Volume: 13
Issue: Suppl 4
Year: 2010
Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS) PDF available

Author(s): Huber M | Ledergerber B | Jaccard R | Elzi L | Furrer H | Hirschel B | Cavassini M | Bernasconi E | Schmid P | Weber R
Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence of type 2 diabetes mellitus and its predictive factors in Italy: a comparison between HIV-infected and uninfected subjects PDF available

Author(s): Galli L | Salpietro S | Pellicciotta G | Galliani A | Piatti PM | Hasson H | Guffanti M | Gianotti N | Bigoloni A | Lazzarin A | Castagna A
Volume: 13
Issue: Suppl 4
Year: 2010
Eligibility for the initiation of HIV treatment in the context of the updated EACS guidelines: results of a clinical audit PDF available

Author(s): Aichelburg MC | Schlag M | Rieger A
Volume: 13
Issue: Suppl 4
Year: 2010
Abstract withdrawn PDF available

Volume: 13
Issue: Suppl 4
Year: 2010
Novel monitoring technique to minimise the risk for patients participating in pilot studies of investigational compounds PDF available

Author(s): Cuffe R | Ait-Khaled M | Hughes S | Min S | Nichols G | Thomas D | Underwood M | Yeo JM
Volume: 13
Issue: Suppl 4
Year: 2010
Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients PDF available

Author(s): Faller EM | Sugden SM | MacPherson PA
Volume: 13
Issue: Suppl 4
Year: 2010
Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meant PDF available

Author(s): Fernandez-Ortega C | Casillas D | Dubed M | Navea L | Ramirez A | Lopez L | Paneque T | Reinoso Y
Volume: 13
Issue: Suppl 4
Year: 2010
No effect of a single supratherapeutic dose of lersivirine, a next-generation NNRTI, on QTc interval in healthy subjects PDF available

Author(s): Vourvahis M | Wong R | Ndongo NM | O'Gorman M | Tawadrous M
Volume: 13
Issue: Suppl 4
Year: 2010
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients PDF available

Author(s): Lagler H | Grabmeier-Pfistershammer K | Touzeau-Römer V | Tobudic S | Rieger A | Burgmann H
Volume: 13
Issue: Suppl 4
Year: 2010
Syphilis infection is associated with an increase in plasma viral load in HIV infected patients: results from the FHDH cohort — ANRS CO4 PDF available

Author(s): Jarzebowski W | Piketty C | de Truchis P | Caumes E | Farhi D | Lascaux AS | Bouldouyre MA | Derradji O | Pacanowski J | Dupin N | Costagliola D | Grabar S
Volume: 13
Issue: Suppl 4
Year: 2010
Causes of death in patients infected with HIV from 1985 to 2008 PDF available

Author(s): Mendez J | Sarmento e Castro R | Domingues da Silva AR
Volume: 13
Issue: Suppl 4
Year: 2010
Clinical profile of HIV/AIDS patients admitted to a tertiary outpatient clinic in Istanbul, Turkey PDF available

Author(s): Aydin Altuntas O | Kumbasar Karaosmanoglu H | Korkusuz R | Nazlican O
Volume: 13
Issue: Suppl 4
Year: 2010
Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment PDF available

Author(s): Perez-Molina JA | Mora-Rillo M | Suarez-Lozano I | Casado JL | Teira R | Rivas P | Pedrol E | Hernando A | Domingo P | Barquilla E | Esteban H | Gonzalez-Garcia J
Volume: 13
Issue: Suppl 4
Year: 2010
HIV testing in non-traditional settings: feasibility and acceptability in an acute admissions unit PDF available

Author(s): Cridford R | Thornton A | Rayment M | Mguni S | Millett D | Mandalia S | Nardone A | Tenant-Flowers M | Sullivan A | Ghosh R | Anderson J
Volume: 13
Issue: Suppl 4
Year: 2010
Cancer chemotherapy: early experience with combined chemotherapy for HIV-infected Kaposi's sarcoma patients at Lighthouse clinic, Lilongwe, Malawi PDF available

Author(s): Mulinde HF | Tweya H | Chiwoko J | Feldacker C | Phiri S | Nyirenda M | Weigel R | Mlundira L
Volume: 13
Issue: Suppl 4
Year: 2010
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma PDF available

Author(s): Cingolani A | Torti L | Pinnetti C | de Gaetano Donati1 K | Murri R | Tacconelli E | Larocca LM | Teofili L
Volume: 13
Issue: Suppl 4
Year: 2010
Abstract withdrawn PDF available

Volume: 13
Issue: Suppl 4
Year: 2010
Relationship between dynamics of Epstein-Barr virus and immune activation in HIV-1 infected subjects in the HAART era PDF available

Author(s): Cattelan AM | Zanchetta M | Sasset L | Petrara R | Freguja R | Gianesin K | Cecchetto MG | Cremona F | De Rossi A
Volume: 13
Issue: Suppl 4
Year: 2010
Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV PDF available

Author(s): Deloof ACA | De Wolf H | Verlinden Y | Villacian J | Pattery T
Volume: 13
Issue: Suppl 4
Year: 2010
The association between metabolic syndrome and the occurrence of nephrolithiasis in HIV-infected patients PDF available

Author(s): Dumitru IM | Rugina S | Sotila G | Dumitru E | Rugina CN
Volume: 13
Issue: Suppl 4
Year: 2010
Intracellular tenofovir-diphosphate accumulation in an HIV-infected patient with Fanconi syndrome and osteomalacia PDF available

Author(s): Haverkort ME | van der Spek BW | Lips PT | Slieker WAT | Bronsveld W
Volume: 13
Issue: Suppl 4
Year: 2010
The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART) PDF available

Author(s): Cassetti I | Etzel A | Madruga JV | Suleiman JM | Zhou Y | Rhee M | Warren DR
Volume: 13
Issue: Suppl 4
Year: 2010
A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial) PDF available

Author(s): Izzo I | Albini L | Calabresi A | Motta D | Bellagamba R | Fezza R | Narciso P | Sighinolfi L | Maggi P | Focà E | Mendeni M | Manili L | Magoni M | Carosi G | Quiros-Roldan E | Torti C
Volume: 13
Issue: Suppl 4
Year: 2010
Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART PDF available

Author(s): Uglietti A | Gervasoni C | Gabrielli E | Di Giambenedetto S | Cauda R | Esposito R | Grima P | Di Perri G | Maserati R | Galli M
Volume: 13
Issue: Suppl 4
Year: 2010
Kidney tubular function and serum phosphate levels in HIV-1-infected patients treated with tenofovir: preliminary results PDF available

Author(s): Grima P | Zizza A | Calabrese P | Chiavaroli R | Faraone A | Tana M | Sodo MR | Tundo P | Guido M
Volume: 13
Issue: Suppl 4
Year: 2010
Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA PDF available

Author(s): Ryom L | Mocroft A | Reiss P | Ledergerber B | De Wit S | Duiculescu D | Monforte AD | Murphy M | Lundgren JD | Kirk O
Volume: 13
Issue: Suppl 4
Year: 2010
CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years PDF available

Author(s): Podzamczer D | Tiraboschi JM | Mallolas J | Cárdenes MA | Casas E | Castro A | Echevarria S | Leal M | Bernanldo de Quirós JC | Moreno S | Puig T | Ribera E | Villalonga C | Gomez Sirvent JL | Garcia Heranejos JA | Lopez-Aldeguer J | Barrufet P | Force L | Santos I | Sanz J
Volume: 13
Issue: Suppl 4
Year: 2010
Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study PDF available

Author(s): Moyle G | Orkin C | Fisher M | Anderson J | Dhar J | Wang MH | Ewan J
Volume: 13
Issue: Suppl 4
Year: 2010
SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients PDF available

Author(s): Kumar P | DeJesus E | Huhn G | Sloan L | Garcia F | Small C | Edelstein H | Felizarta F | Hao R | Ha B | Stancil B | Ross L | Oie K | Pappa K
Volume: 13
Issue: Suppl 4
Year: 2010
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study) PDF available

Author(s): Rodriguez JM | Delgado M | Viciana P | Lopez-Ruz MA | Leal M | Alcacer F | Deig E | Antela A | Pedrol E | Moreno S
Volume: 13
Issue: Suppl 4
Year: 2010
Altered phosphate metabolism in HIV-1-infected patients: another feature of metabolic syndrome? PDF available

Author(s): Grima P | Zizza A | Guido M | Calabrese P | Chiavaroli R | Sodo MR | Tana M | Tundo P
Volume: 13
Issue: Suppl 4
Year: 2010
Dietician-based approach to lipodystrophic syndrome: role of bioelectrical impedance analysis at week 12 PDF available

Author(s): Orofino G | Guastavigna M | Martinoglio P | Penoncelli D | Demarie D | Tettoni M | Desiderato P | Di Frenna R | Zignin C
Volume: 13
Issue: Suppl 4
Year: 2010
Nutritional status in HIV-infected patients using Changi's mini nutritional assessment PDF available

Author(s): Cervero M | Alcázar V | Sanz R | García-La Calle C | Agud JL
Volume: 13
Issue: Suppl 4
Year: 2010
Adiponectin and leptin levels in HIV-infected patients with lipodystrophy in Southern India PDF available

Author(s): Jacob S | Phoebe K | Hemalatha R | Sivakumar MR | Ravindran MP | Natarajan MV
Volume: 13
Issue: Suppl 4
Year: 2010
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir PDF available

Author(s): Overton T | Aberg JA | Gupta S | Ryan R | Baugh B | De La Rosa G
Volume: 13
Issue: Suppl 4
Year: 2010
Hypertriglyceridemic waist identifies HIV+ men and women at increased cardiometabolic risk PDF available

Author(s): Guaraldi G | Zona S | Orlando G | Carli F | Stentarelli C | Despres J | Ross R
Volume: 13
Issue: Suppl 4
Year: 2010
Mesenteric fat thickness in a group of HIV patients on HAART PDF available

Author(s): Lee SS | Liu E | To KW
Volume: 13
Issue: Suppl 4
Year: 2010
Lipodystrophy and metabolic syndrome in Romanian HIV-infected adults PDF available

Author(s): Arbune M
Volume: 13
Issue: Suppl 4
Year: 2010
Alexithymia, an impairment of emotional cognitive processing, is a candidate risk factor for carotid artery plaque formation in HIV-infected patients PDF available

Author(s): Vadini F | Sozio F | Mazzotta E | Agostinone C | Ursini T | Agostinone A | Placido G | Manzoli LM | Parruti G
Volume: 13
Issue: Suppl 4
Year: 2010
5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) PDF available

Author(s): Lazzarin A | Johnson M | Ribera E | Weitner L | Chen SS | Warren DR
Volume: 13
Issue: Suppl 4
Year: 2010
Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients PDF available

Author(s): Puerta S | Gallego M | Palacios R | Ruiz J | Nuño E | Márquez M | Santos J
Volume: 13
Issue: Suppl 4
Year: 2010
Nitric oxide protects against HIV gp120 endothelial injury PDF available

Author(s): Fiorucci S | Mencarelli A | Francisci D | Distrutti E | Renga B | Baldelli F
Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates PDF available

Author(s): Golf JP | Sala L | Aramburo J | Sardà P | Perez-Alvarez N | Llibre JM
Volume: 13
Issue: Suppl 4
Year: 2010
Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients PDF available

Author(s): Grima P | Guido M | Chiavaroli R | Tundo P | Zizza A
Volume: 13
Issue: Suppl 4
Year: 2010
Incidence of ischemic cardiovascular events in the maraviroc clinical development program PDF available

Author(s): Portsmouth S | Burnside R | Lazzarin A | Johnson M | Valdez H
Volume: 13
Issue: Suppl 4
Year: 2010
Cardiovascular risk in patients visiting the Hadassah AIDS Center, Jerusalem PDF available

Author(s): Schulman S | Rotshild V | Pops K | Korem M | Israel S | Hauzi M | Maayan S
Volume: 13
Issue: Suppl 4
Year: 2010
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy PDF available

Author(s): Palacios R | González-Correa JA | Ruiz J | Nuño E | Márquez M | de la Cruz JP | Santos J
Volume: 13
Issue: Suppl 4
Year: 2010
Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovir PDF available

Author(s): Francisci D | Falcinelli E | Belfiori B | Petito E | Mezzasoma M | Baldelli F | Gresele P
Volume: 13
Issue: Suppl 4
Year: 2010
Immune impairment and adaptive response in relation to antiretroviral therapy of HIV-infection PDF available

Author(s): Kaminskiy GD | Pronin AJ
Volume: 13
Issue: Suppl 4
Year: 2010
Long-term efficacy and safety of low-dose ritonavir-boosted atazanavir (ATV/r) 200/100 mg in HIV-infected Thai patients PDF available

Author(s): Avihingsanon A | Apornpong T | Kerr SJ | Ananworanich J | Ruxrungtham K
Volume: 13
Issue: Suppl 4
Year: 2010
Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir PDF available

Author(s): Nozza S | Galli L | Di Pietro M | Mazzotta F | Canducci F | Pogliaghi M | Chiappetta S | Galli A | Rusconi V | Salpietro S | Tambussi G | Lazzarin A
Volume: 13
Issue: Suppl 4
Year: 2010
Abstract withdrawn PDF available

Volume: 13
Issue: Suppl 4
Year: 2010
British HIV and ageing study. HIV and ageing: older people with HIV, who are they? PDF available

Author(s): Allan S | Daly RA | Yoganathan Y | Barrett S | Joseph A | Tariq A | Saing CW | Williams C | Lane C | Sikorska J
Volume: 13
Issue: Suppl 4
Year: 2010
Prediction of virological failure in HIV-infected individuals treated with cART in Suriname PDF available

Author(s): Bleijenberg MP | Bierman WFW | Jaglall C | Heymans MW | ten Doesschate MC | Nieuwkerk PT | Smits PH | van Eer M | Vreden S
Volume: 13
Issue: Suppl 4
Year: 2010
The prognosis of patients with dissociated virological and immunological responses to HAART PDF available

Author(s): Jevtovic DJ | Salemovic DR | Ranin JT
Volume: 13
Issue: Suppl 4
Year: 2010
Treatment of HIV-2 infection: a retrospective study from a Portuguese center PDF available

Author(s): Marques N | Seixas D | Crespo P | Malcata L | Vaz J | Mota V | Morais C | Oliveira J | Duque V | Saraiva da Cunha J | Meliço-Silvestre A
Volume: 13
Issue: Suppl 4
Year: 2010
Epidemiological description of the demographic and HIV disease characteristics of HIV patients who are in care but not on treatment in Spain PDF available

Author(s): Domingo P | Arazo P | Casado JL | Castaño MA | Ferrer E | Goenaga MA | Granados R | Pulido F | Rodriguez J | Rubio R | Sanz J | Viciana P
Volume: 13
Issue: Suppl 4
Year: 2010
Changes in cerebral function parameters in HIV-1 infected subjects undergoing a treatment simplification to darunavir/ritonavir PDF available

Author(s): Garvey LJ | Higgs C | Mohammed P | Nelson M | Winston A
Volume: 13
Issue: Suppl 4
Year: 2010
Switching to dual therapy with darunavir/ritonavir and etravirine: a simplification strategy PDF available

Author(s): Tyrer M | Swaden L | Marshall NJ | Johnson M
Volume: 13
Issue: Suppl 4
Year: 2010
Lopinavir/ritonavir monotherapy in clinical practice PDF available

Author(s): Caso A | Valencia E | Moreno V | Cervero M | Sanz J | Torres Perea R
Volume: 13
Issue: Suppl 4
Year: 2010
Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data PDF available

Author(s): DeJesus E | Mills A | Bhatti L | Conner C | Storfer S
Volume: 13
Issue: Suppl 4
Year: 2010
Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA PDF available

Author(s): Casado JL | Domingo P | Rubio R | Antela A | Lopez-Ruz MA | Castro A | Portilla J | Ribera E | Podzamczer D | Oteo JA | Galindo J | Otero S | Lozano F | Estrada V | Moltó J | Moreno S
Volume: 13
Issue: Suppl 4
Year: 2010
Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting PDF available

Author(s): Bonora S | Calcagno A | Viganò O | Bigliano P | Rusconi S | Trentini L | Tettoni MC | Orofino G | Salassa B | Bramato C | D'Avolio A | Siccardi M | Colella E | Galli M | Di Perri G
Volume: 13
Issue: Suppl 4
Year: 2010
Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome PDF available

Author(s): Baudry T | Boibieux A | Gagnieu MC | Cotte L | Livrozet JM | Miahles P | Makhloufi D | Chidiac C | Peyramond D | Ferry T
Volume: 13
Issue: Suppl 4
Year: 2010
Lopinavir to atazanavir or darunavir switch in HIV-1-infected patients with dyslipidemia: an observational study PDF available

Author(s): Le Moal G | Beraud G | Prazuck T | Hocqueloux L | Dupuis A | Venisse N
Volume: 13
Issue: Suppl 4
Year: 2010
48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION) PDF available

Author(s): Arastéh K | Ward A | Plettenberg A | Livrozet JM | Cordes C | Winston A | Wang E | Quinson A
Volume: 13
Issue: Suppl 4
Year: 2010
Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort PDF available

Author(s): Cuzin L | Allavena C | Levy-Bachelot L | Valantin MA | Mellliez H | Pugliese P | Poizot-Martin I | Duvivier C | Finkielsztejn L | Abel S
Volume: 13
Issue: Suppl 4
Year: 2010
Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study PDF available

Author(s): Martínez E | Arranz JA | Podzamczer D | Lonca M | Sanz J | Barragán P | Knobel H | Ribera E | Gutierrez F | Valero S | Clotet B | Dalmau D | Segura F | Arribas JR | Barrufet P | Santos I | Payeras A | de Lazzari E | Pich J | Gatell J
Volume: 13
Issue: Suppl 4
Year: 2010
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug PDF available

Author(s): Billaud E | Lacombe JM | Abgrall A | Ghosn J | Launay O | Livrozet JM | Meynard JL | Pavie J | Costagliola D
Volume: 13
Issue: Suppl 4
Year: 2010
Fracture risk in HIV and the need for guidelines: the Probono-1 Trial PDF available

Author(s): Peters B | Isohanni H | Tillet S | Ibrahim F | Hampson G | Williams FMK | Perry MEO | Duncan A | Wierzbicki A
Volume: 13
Issue: Suppl 4
Year: 2010
Quantitative ultrasound (QUS) in HIV-infected patients: a reliable and low-cost technique for bone health assessment PDF available

Author(s): Marocco R | Martini H | Belvisi V | Tieghi T | Cesareo R | Del Borgo C | Lichtner M | Mastroianni CM
Volume: 13
Issue: Suppl 4
Year: 2010
Markers of bone turnover are elevated in patients on antiretrovirals independent of the substance used PDF available

Author(s): Piso RJ | Rothen M | Rothen JP | Stahl M
Volume: 13
Issue: Suppl 4
Year: 2010
Lack of association between mitochondrial DNA polymorphisms and didexoxynucleoside-induced hyperlactataemia in black-African, HIV-1-infected patients PDF available

Author(s): Arenas-Pinto A | Weller I | Ekong R | Grant A | Karstaedt A | Telisinghe L | Bolhaar M | Charalambous S | Bradman N | Ingram C
Volume: 13
Issue: Suppl 4
Year: 2010
Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline PDF available

Author(s): de Jong E | Haverkort ME | ter Heine R | Jansen RS | Beijnen JH | van Agtmael MA
Volume: 13
Issue: Suppl 4
Year: 2010
A case of nodular regenerative hyperplasia in a patient who had been taking didanosine PDF available

Author(s): Jackson C | Fox R | Priest M | Clutterbuck D | Peters E
Volume: 13
Issue: Suppl 4
Year: 2010
Clinical significance of hyperbilirubinemia in the CASTLE study PDF available

Author(s): Uy J | Hu W | Wirtz V | Hosey T | Butcher D | McGrath D | Farajallah A
Volume: 13
Issue: Suppl 4
Year: 2010
Liver fibrosis: concordance analysis between APRI and FIB-4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infection PDF available

Author(s): Mendeni M | Focà E | Gotti D | Ladisa N | Quiros-Roldan E | Vavassori A | Castelnuovo F | Carosi G | Angarano G | Torti C
Volume: 13
Issue: Suppl 4
Year: 2010
Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients PDF available

Author(s): Macías J | Mallolas J | López-Cortés LF | Cartón JA | Domingo P | Moreno S | Iribarren JA | Neukam K | Rodrigo A | Jiménez-Expósito MJ | Pineda JA
Volume: 13
Issue: Suppl 4
Year: 2010
Hepatotoxicity in patients co-infected with HIV and tuberculosis while receiving NNRTI-based antiretroviral regimen and rifampicin PDF available

Author(s): Mankhatitham W | Lueangniyomkul A | Manosuthi W
Volume: 13
Issue: Suppl 4
Year: 2010
HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC) PDF available

Author(s): Baran RW | Dietz B | Fredrick LM | Tian M | Podsadecki T
Volume: 13
Issue: Suppl 4
Year: 2010
Prevalence of chronic renal failure stage 3 or more in HIV-infected patients in Antwerp: an observational study PDF available

Author(s): Colson AW | Florence E | Augustijn H | Verpooten GA | Lynen L | Gheuens E
Volume: 13
Issue: Suppl 4
Year: 2010
The role of the ubiquitin-proteasome pathway in rhTRIM5α restriction of HIV-1 PDF available

Author(s): Danielson CM | Hope TJ
Volume: 13
Issue: Suppl 3
Year: 2010
Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1 PDF available

Author(s): Kuhl BD | Sloan RD | Donahue DA | Bar-Magen T | Liang C | Wainberg MA
Volume: 13
Issue: Suppl 3
Year: 2010
Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells PDF available

Author(s): Evans VA | Saleh S | Haddad EK | Cameron PU | Sekaly R-P | Lewin SR
Volume: 13
Issue: Suppl 3
Year: 2010
Homeostatic proliferation of memory T cells and expansion of the HIV-1 latent reservoir PDF available

Author(s): Bosque A | Planelles V
Volume: 13
Issue: Suppl 3
Year: 2010
HIV-1 Tat complexes reveal subunit composition of active P-TEFb and stable association with 7SKsnRNP PDF available

Author(s): Sobhian B | Laguette N | Yatim A | Nakamura M | Levy Y | Kiernan R | Benkirane M
Volume: 13
Issue: Suppl 3
Year: 2010
Novel pathways of transcriptional and post-transcriptional regulation of post-integrative HIV-1 latency PDF available

Author(s): Marcello A | Kula A | Dieudonne M | Knezevich A | Maiuri P
Volume: 13
Issue: Suppl 3
Year: 2010
Where are macrophage-tropic viruses? PDF available

Author(s): Schnell G | Joseph S | Spudich S | Price R | Swanstrom R
Volume: 13
Issue: Suppl 3
Year: 2010
Most HIV DNA in PBMC is present in non-gut homing, resting memory CD4+ T cells with a ß7-CD38-CD127 high phenotype PDF available

Author(s): Koelsch KK | Xu Y | Bailey M | McBride K | Seddiki N | Suzuki K | Murray J | Cooper DA | Kelleher AD | Zaunders J
Volume: 13
Issue: Suppl 3
Year: 2010
CD4+ T cell reconstitution, T cell activation, and memory T cell subset composition in blood and gut of HIV-negative and ART-suppressed HIV-positive patients: implications for HIV persistence in the gut PDF available

Author(s): Yukl S | Sinclair E | Epling L | Li Q | Shergill A | McQuaid K | Duan L | Hare B | Lampiris H | Haase A | Havlir D | Wong J
Volume: 13
Issue: Suppl 3
Year: 2010
Measurements of total and integrated HIV DNA demonstrate sporadic blips of unintegrated HIV DNA in HIV-positive patients on HAART PDF available

Author(s): Mexas A | Graf E | Agosto L | Yu JJ | Pace M | Liszewski M | Migueles S | Connors M | O’Doherty U
Volume: 13
Issue: Suppl 3
Year: 2010
Affiliate Program      Why do you need a reservation system?